Professor Luke O’Neill is Professor of Biochemistry at Trinity College Dublin. Through his pioneering work, he has become recognised as a world leader in the fields of immunology and inflammatory diseases such as rheumatoid arthritis.

He was appointed to the Chair of Biochemistry at Trinity College Dublin in 2008, where he leads the Inflammation Research Group. He is also academic director of the Trinity Biomedical Sciences Institute. He is a co-founder and director of Opsona Therapeutics, a drug development company working in the area of Toll-like receptors.

He has published over 220 papers in journals such as Nature, Science, Cell, Nature Immunology, Nature Medicine, Nature Genetics and PNAS. He is on the editorial boards of 6 journals, including the Journal of Biological Chemistry and Trends in Immunology. He is also on the board of Reviewing Editors for Science, covering innate immunity. In 2008 he was appointed Chair of the Immunity and Infection panel of the European Research Council.

He has won numerous awards for his internationally recognised research, notably the Royal Irish Academy Medal for Biochemistry, The Irish Society for Immunology medal, the Royal Dublin Society/ Irish Times Boyle medal for Scientific Excellence and the Science Foundation Ireland Researcher of the Year Award 2009. Professor Luke O’Neill has been a Member of the Royal Irish Academy since 2004.